Table 3.
Outcome | Sex | Model 1a OR (95% CI) |
P | Model 2b OR (95% CI) |
P | Model 3c OR (95% CI) |
P |
---|---|---|---|---|---|---|---|
Opioids | Female (ref = Caucasian) | 1.14 (0.59–2.21) | .694 | 1.13 (0.61–2.11) | .696 | 1.01 (0.53–1.90) | .984 |
Male (ref = Caucasian) | 0.69 (0.30–1.59) | .388 | 0.94 (0.40–2.22) | .885 | 0.88 (0.39–1.99) | .752 | |
Nonopioids | Female (ref = Caucasian) | 0.83 (0.37–1.85) | .647 | 0.97 (0.48–1.98) | .936 | 0.92 (0.47–1.81) | .818 |
Male (ref = Caucasian) | 1.25 (0.44–3.53) | .677 | 1.51 (0.47–4.86) | .495 | 1.70 (0.46–6.22) | .425 | |
Antiemetics | Female (ref = Caucasian) | 0.97 (0.50–1.88) | .935 | 1.42 (0.78–2.58) | .250 | 1.71 (0.93–3.12) | .085 |
Male (ref = Caucasian) | 1.07 (0.47–2.41) | .878 | 0.82 (0.35–1.92) | .642 | 0.82 (0.33–2.03) | .664 | |
Degrees of freedom | 3 | 13 | 34 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Unadjusted.
Adjusted for: age, pain scale, region, number of comorbidities.
Adjusted for: model 2 + emergent, working hours, day, month, year.